Arcus Biosciences's total assets for Q3 2025 were $974.00M, a decrease of -9.40% from the previous quarter. RCUS total liabilities were $538.00M for the fiscal quarter, a 2.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.